Alan Buckler,Gregory J. Carven,Stefan Wawersik,Thomas Schurpf,Constance Martin,Abhishek Datta,Mark Allen Farmer
申请号：
US16611029
公开号：
US20200181251A1
申请日:
2018.05.09
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed herein are LRRC33 inhibiting agents and related methods and uses thereof. More specifically, therapeutic agents for inhibiting LRRC33 effects in vivo are provided. Such agents are useful for the treatment of various disorders involving cells expressing LRRC33 or LRRC33-containing complexes on the surface of cells.
